impacted or the remains safe personal has good difficult at time. to effects go us hardship all workplace, this hope and call of that who hearts We or and health COVID-XX our during been out joining suffered on in home pandemic unprecedented everyone evening. loss. good and the the Sylvia, you, in by Whether we this and have Thank everyone
selflessly go on also global out lines are hearts pandemic. this the health to Our fighting the world, care workers front the around who
first CEO, thank I and the leadership. call and As last my like since in of confidence being during this Board for named quarterly the several support their is for President to their months Directors would my
I to As had past a unique help then its interim to realized guide opportunity evolution. and as member Anika leverage experiences Board I a my CEO, through that continued
working operational and periods chosen growth. scaling, led leadership been the team of continue drive am successfully growth, excited to through have with to even significant and the I I businesses disruption. have integration and Anika to humbled commercial very momentum and company's
I acquisitions strong taking orthopedic products with Anika's operational to the commercial about the needs patient CEO also growth unmet of company tremendous significant the opportunity: tremendous and Arthrosurface of and permanently, role the that a I value on financial the considered segments engine present. attractive market excellence I As innovation, of I true deliver culture opportunities market. transformative and thought in address about about thought Parcus they Anika's discipline. and recent and thought
several for exceptional this long attend a and enough come to team to leadership as as strong to having hopefully, last forward as Anika Anika to well as opportunity. have investor the possible soon, see benefit team, the look we virtual create to identify then, of months, already employees. in worked know in-person and shareholders. months to better that I opportunities I and weeks has investors coming value events. getting over have and short, And talented the appreciate In I beside Anika's continue presents passionate we and patients what new is analysts an
to first how #X. our navigating Slide turn results, evolving discuss and has quarter been the to like business environment. COVID-XX update Please I'd outlook, Anika into diving Before
March. our of serve. middle to First been able and since have have and who foremost, we Anika and employees the necessary patients well-being are to health we work steps so communities the taken employees, safeguard All of our doing remotely the the
and U.S. and closely the in local from World state monitor abroad. to continue the and follow Organization, CDC, authorities the and guidance We Health
and new to like our of normal their our and their partners employees, to while for families remote of and all distancing. thank social the adjusting extraordinary work efforts commitments, I'd
supply Our best manufacturing guidance keep And and following public practices those chain authorities operations in safe. employees from disruption. continued have to minimal with health areas and are
therapies monitoring patients to supply in not coordinated this medical distribution Our have adjusting anticipate the actively surgery to COVID-XX are ordering respond to facilities and partners changes disruption closely centers do and and implants patients the our we for operations to team treatments and with access At the manufacturing and to to patterns. temporary uninterrupted they ensure need. have time, of due customer
clinical to sites at detail partners other trials are continue activities so ongoing safely to that determining COVID-XX trial shortly. in when and accelerate same COVID goals the lessens. impact efforts our and time, patient studies. can disruption we We of ongoing while to maintain those those studies, have safety the on more been We'll the working The clinical the with impact minimize discuss
to have We to equipment donation and of also worked the with on and includes lines. clinics urgent care front to local meet workers partners delivery This the providers. health the supplies industry health of care donate needs personal protective
and controls ready and maintain to successfully important balance we lastly, ensure swift have healthy COVID-XX positioned are we a and navigate have our sheet. steps for uncertainty recovery. And to of we strong that our best liquidity short-term strengthen to expense Internally, the are through taken implemented
with needs possible. prioritized to opportunities longer-term also align business key have initiatives to help near-term and balance expenditures We where
in our I'd driven Joint year-over-year quarter legacy Anika strong the some portfolios the growth quarter in pain highlight XX% our by and double-digit following and in revenue of We contribution Preservation Restoration surgical to delivered first Arthrosurface. portfolio growth acquisitions to the Parcus decidedly management turn recent Now strong our from of recent joint a like and progress total and made achievements. of a
management XX% doubled year-over-year, close revenue, pain grew joint International therapies CINGAL global year-over-year. to
quarter in We continue recently sheet. ended our investment expand of with received We and balance approval cash marketing CINGAL on of $XX our geographic million and Australia. to the penetration
As I closed early late acquisitions and during we the noted earlier, January respectively. Arthrosurface Parcus February, in the and quarter,
Colleran ability also execute Corporate plan X-year preservation to newly to achievements a David the our successfully President, These and on of Vice and strengthen created joint We in position position Secretary. and our General Counsel leadership appointed achieve Executive strategic restoration.
pleased first of are forecast being year worldwide. our and rest temporarily for this procedures has are in suspended or our COVID-XX with the quarter ability results results our elective to we as impacted countries progress, business While postponed
our withdrawing we full situation future impacting practices visibility XXXX improves. result, guidance which in a February intend our when are our guidance, issued the into year to trends revenue As to We reinstate we the financial COVID-XX prior business.
handled will The big pace In will orders pre-COVID-XX making it the approaches take is address varying Anika, taking the pre-COVID state-by-state that to are countries largely elective pandemic recover be question as regionally are a similar is to to returning The based volumes. combating policy how is and being determined impact outlook working city-by-city recovery back for and even long phased and on procedures COVID-XX operations. many, local on U.S., to international The COVID-XX. and of basis. to the overall of including
is Parcus While some we purchase the are the affecting help for products portfolio. fulfill reflects continuing orders and of ORTHOVISC Anika's significantly elective and to procedure This Arthrosurface to MONOVISC. diversified from resiliency procedures been delays expected have impacted, near-term and legacy revenue offset the of impact
postponed, important trends procedures our monitoring not analyzing of are are that It's remember closely manage We procedure many to we inventory. and volumes as these canceled.
and so taking patients will we to ready is our serve the procedures support and when steps, Our customers they continue return we trajectory top making priority be the growth these our strong necessary positioned are sure post-COVID-XX. to
to like I'd discuss road ahead. for the our strategy Now
resulted Anika's of commercial surgical have and and care normal time, both of delivered scheduled painful the once expect in importance and conditions, and of Because At Let's we in-office same and procedures start in prioritization and in orthopedic system the we to address treatments both procedures know COVID-XX settings. and what health innovative and as the delayed. offer, office-based significant lift suspended we levels. volumes therapies on with a demands today. return cases robust recovery and emergency the products surgical restrictions elective procedures being elective
as multiple of can. tracking commercial are with channels situation returning the as the goal we We quickly full to actively through activity soon
monitoring surgery our are office-based leading including we contact with and customers We are distributors. center activity, and hospital, regular direct and in and indicators,
We are around surgical determine productive regional how globe and to safely normal planning commercial maintaining to partners with are activities. and the frequent phase in business authorities dialogue
opportunity our our impacts And understand partnered teams support challenge closely direct analyze are across an to activities the will network data optimize regions periods. monitoring to order we moving to represent developments and We in activity. those with areas commercial remain overlaying to early followed to or full longer react by competitive clinical might and that global return activity our and first, we in for are where
vigilant continue while implementing key to maintaining success. and the readiness to be ability will Our analysis flexibility our
contribute also normal during and us this will Our U.S. gradually return expenses this more of procedural success period by scale to as efficiently, enabling regional level. model rapidly a new more to particularly hybrid commercial in the to volumes uncertainty respond
to and trial to health Slide on adopted of existing turn trials, care safely applicable. X. professionals I the investigators, safety guidelines, with key to patients, at stakeholders and patients engaging the including respect ecosystem, clinical the a programs fully are providers responsibility we where we policy with trial facilities Please all clinical with recent focus a maintaining sites. have Consistent clinical FDA in service and
leveraging For in-person delaying ongoing we virtual are communication and trials, tools visits.
challenges. half CINGAL enrollment begin year. and no new in deferred first due initiations of the of we trial to have these we pilot the to factors, COVID-XX-related study new expect patient this site longer Additionally, Because
study a activities are pilot in a at initiated substantially have as pre-enrollment patient activity for the not and convenient pause we Fortunately, complete, was enrollment. relatively temporary point
to study are pilot commence and enrolling to begin to clinical can we closely continue intend safely as as so. We the sites monitor We soon we as the situation. patients eager do
III Enrollment trial quarter temporarily in paused was impacted HYALOFAST the also in in the Phase and April. first was
patient we end no result, by year. complete the a to this of As enrollment longer expect
outside to We new activities to managing several trial we trial U.S. enrollment are expanding the COVID-XX, sites made countries the of actively disruption. the to in by Prior improve minimize efforts pace of
locations site We completed initiation initiation have clinical move safe and to the complete activities pre as and and of the enrollment Mexico, well-qualified is site Philippines Indonesia as to in it are that soon identified much at forward. begin
application are COVID-XX, light XXX(k) time. this repair On for the a rotator our XXXX. we this in the early cuff product development submitting In FDA front, we previously expectation withdrawing of anticipated at therapy to
are a able provide the CINGAL, development normal on for more trial and time impacts have and we programs cuff will frame more the rotator and restart visibility We length activities development of when HYALOFAST the definitive pandemic. to COVID-XX regional and
sales recent gathering our sales on common after national well-defined an we map our update held teams, associated to an provide with In It ongoing with executives, Turning high combined #X. achieve integration and shortly tools key of energy both the teams. partners activities vision of Parcus the first now February, acquisitions Slide a Arthrosurface. the meeting I'll armed completing road exciting was transactions, them. necessary of commercial and with to all direct goals, and
an the product team we was energized for we business more product from and daily creative combined base. encouraging In have portfolio. had momentum larger to grow recent look opportunities result global to cross-training sessions The diverse and ideas newly the weeks, cross-selling team, as product commercial educate on the a
education on we April, with engage early surgeon virtual have also through virtual training our Anika to These sessions the peer-to-peer on Since community our products. focusing medical continued surgeon program. are
procedural elective second accelerating for the year. volumes of around We expect with of pace surgical half start procedures medical reopening the the potentially midyear, in facilities to
necessary is as ready commercial hit ground ensure taking soon are safely all We the team the as possible. our steps to running to
the It particularly exciting This to fully our fueled patients to help one, organization becoming a our is leverage light this teams very global product has need. to in across portfolio in of see three innovative passion crisis.
the aligning energized is as team we chapter important in future story. is and this next look Anika's to Our and
now our quarter will call I to review financial XXXX turn Sylvia Sylvia? results. the to over first
